If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNetscientific Regulatory News (NSCI)

  • There is currently no data for NSCI

DeepTech Recycling: Fundraising, Business Update

31 May 2024 07:00

RNS Number : 5445Q
NetScientific PLC
31 May 2024
 

NetScientific plc

("NetScientific", the "Group" or the "Company")

DeepTech Recycling: Fundraising and Business Update

NetScientific plc (AIM: NSCI), the deep tech and life sciences VC investment group, announces that its portfolio company, DeepTech Recycling Limited ("Deeptech Recycling"), a plastic recycling technology business offering an innovative solution to the environmental challenges of plastic pollution, has successfully closed a £0.8 million fundraising ("Fundraising"), with the combined investment amount which includes a prior close being £2.1 million (further details below).

Fundraising

The Fundraising follows a first closing of £1.0 million via an advanced subscription agreement ("ASA") that was completed in December 2023 and a second close of the ASA of £0.3 million shortly thereafter. The investment includes the aforementioned advance subscription amounts. As outlined in the announcement of 1 December 2023, the proceeds of the Fundraising will, inter alia, continue to support DeepTech Recycling in the completion of a development phase for its pilot plant, development and adaption of its targeted technology and licensing strategy, as well as the set-up of its operating base and development of its core team.

The Fundraising was led and syndicated by EMV Capital, the Company's wholly owned venture capital and corporate finance firm, and alongside new investors includes further investment from EMV Capital's EMVC Evergreen EIS Fund.

In December 2022, DeepTech Recycling was set up as a special purpose vehicle to acquire the majority of the assets of Recycling Technologies from the administrator, with NetScientific acquiring a 30% stake at near nil value. Following the Fundraising, the Company's direct stake in DeepTech Recycling will be 21.2% on a fully diluted basis. This equates to a post-investment fair value uplift of £1.8 million. The capital under advisory of EMV Capital in respect of investors introduced by it to DeepTech Recycling is £2.1 million, representing 29.3% of the captable on a fully diluted basis.

Business update

DeepTech Recycling has developed a chemical recycling solution for different types of plastic waste. The company is committed to making plastic sustainable and supporting the global drive towards a circular economy for plastics through the chemical recycling of plastic waste.

Since the fundraise announced on 1 December 2023, DeepTech Recycling has made significant progress, including:

· The signing of a Memorandum of Understanding to develop a commercial plastics recycling facility in the UK, with a purchase order received for the first stage of the facility development project.

· For a second project, the identification by DeepTech Recycling of a shortlist of sites and strategic partners for a 7,000-tonne per annum project.

· The progression of an appointment process of a FEED/EPC contractor, from a high-profile shortlist.

· The enhancement of DeepTech Recycling's team through strategic hires of new employees. The company has also welcomed Jonathan Seville, previously President of the Institution of Chemical Engineers and Executive Dean of Engineering and Physical Sciences at the University of Surrey, as a Technical Adviser.

· New premises have been secured and set up with labs and a testing plant in Oxfordshire, which will provide the crucial infrastructure to ensure focus on the technology development.

Dr Ilian Iliev, CEO of NetScientific and Interim Chair of DeepTech Recycling, commented:

"Marvine and his team have effectively leveraged the recent fundraise, accelerating DeepTech Recycling through critical development phases. We are excited to support their progress in major projects in the UK and internationally. This journey perfectly exemplifies our capital efficient and value-creation strategy, turning a once undervalued and distressed asset, effectively valued at zero in 2022, into a thriving venture, and providing NetScientific shareholders with a significant and valuable stake at minimal cost."

Marvine Besong, Managing Director and CTO of DeepTech Recycling, added:

"EMV Capital has provided a unique support package, helping our team to restart and accelerate progress with DeepTech Recycling, and to access a supportive investor base that is committed to ESG and real impact in the plastic waste management space. It is only 1.5 years since the start of the company, we are now poised to take on exciting projects in the UK and internationally, driving sustainability in plastics and transforming waste into high-value resources. The future looks promising for DeepTech Recycling."

 

The person responsible for arranging the release of this announcement on behalf of the Company is Ilian Iliev, CEO of the Company.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE UK VERSION OF REGULATION (EU) NO 596/2014 WHICH IS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

-Ends-

 

For more information, please contact:

 

NetScientific

Ilian Iliev, CEO

Via Belvedere Communications

 

Panmure Gordon (UK) Limited (NOMAD and Broker)

 

Emma Earl / Will Goode / Freddy Crossley / Mark Rogers (Corporate Finance)

Rupert Dearden (Corporate Broking)

+44 (0)20 7886 2500

Belvedere Communications

John West / Llewellyn Angus / Lily Pearce

 

+44 (0)20 7653 8702

 

About NetScientific

NetScientific plc (AIM: NSCI) is a deep tech and life sciences VC investment group with an international portfolio of innovative companies.

NetScientific identifies, invests in, and builds high growth companies in the UK and internationally.

The company adds value through the proactive management of its portfolio, progressing to key value inflection points, and delivering investment returns through partial or full liquidity events.

NetScientific differentiates itself by employing a capital-efficient investment approach, making judicial use of its balance sheet and syndicating investments through its wholly owned VC subsidiary, EMV Capital. The group secures a mixture of direct equity stakes and carried interest stakes in its portfolio of companies, creating a lean structure that can support a large portfolio.

NetScientific is headquartered in London, United Kingdom, and is admitted to trading on AIM, a market operated by the London Stock Exchange.

www.netscientific.net

 

About Deeptech Recycling

DeepTech Recycling is a UK-based technology company born out of a global environmental crisis caused by insufficient and unsustainable management of plastic waste. The company's mission is to make plastic sustainable and support the critical global drive towards a circular economy for plastics.

DeepTech Recycling has a unique, patented and demonstrated technology platform, which was developed over more than 10 years of structured and accelerated development and commercialisation, and offers a unique innovative solution to the environmental challenges of plastic pollution.

The technology converts currently unrecyclable plastic waste, that would normally be landfilled or incinerated, into oil that can be used by the petrochemical industry as the feedstock for producing virgin quality plastic.

https://www.deeptech-recycling.co.uk/

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDBRGDUSGXDGSG
Date   Source Headline
16th Sep 20242:31 pmRNSPDS: Updated Results, VERSATILE-002 Phase 2 Trial
13th Aug 20243:57 pmRNSPDS Biotech: Business Update and Q2 2024 Results
2nd Aug 202412:21 pmRNSReplacement RNS: PDS Biotech Aligns with FDA
2nd Aug 20247:00 amRNSPDS Biotech Aligns with FDA on Phase 3 Trial
30th Jul 20247:00 amRNSQ-Bot Fundraising
10th Jul 202410:48 amRNSResult of AGM
18th Jun 20247:00 amRNSNotice of AGM
14th Jun 20242:10 pmRNSTR-1
14th Jun 20247:00 amRNSDirector/PDMR Shareholding
13th Jun 20247:00 amRNSPreliminary Results for the year ended 31 Dec 2023
31st May 20247:01 amRNSNotice of Results and Investor Presentation
31st May 20247:00 amRNSDeepTech Recycling: Fundraising, Business Update
28th May 20247:00 amRNSInvestment in Wanda, related party transactions
15th May 20242:32 pmRNSPDS Biotech: Business Update and Q1 2024 Results
13th May 20247:00 amRNSMartlet Capital: mandate and acquisition
10th May 20249:12 amRNSPDS Biotech: Clinical trial meets study endpoints
15th Apr 20247:00 amRNSProAxsis secures c.£1.8mn investment
27th Mar 20241:34 pmRNSPDS Strategy Update and 2023 Financial Results
13th Mar 20247:00 amRNSBusiness Update
5th Feb 20247:00 amRNSExercise of Options and Issue of Shares
23rd Jan 20247:00 amRNSGlycotest secures $1 million investment
1st Dec 20237:00 amRNSDeepTech Recycling secures £1 million investment
14th Nov 20234:39 pmRNSPDS BioTechnology: Third Quarter Results
13th Nov 20237:00 amRNSDirector/PDMR Shareholding
9th Nov 20235:28 pmRNSPDS Biotech Announces Updated Survival Data
6th Nov 20237:00 amRNSVentive secures c.£900,000 investment
2nd Nov 20237:00 amRNSChange of Adviser
23rd Oct 20236:22 pmRNSPDS Preliminary Biomarker Study Results
13th Oct 20237:00 amRNSExercise of Options
3rd Oct 20234:12 pmRNSDirector/PDMR Shareholding
3rd Oct 20233:21 pmRNSPDS: Interim 24-month survival rate of 74% update
3rd Oct 20237:00 amRNSPDS Biotech: new data on PDS0101
28th Sep 20237:00 amRNSInterim Results
13th Sep 20237:00 amRNSQ-Bot: £3.5 million investment to drive expansion
14th Aug 20235:55 pmRNSPDS Biotech: 2nd Quarter Results, Business Update
14th Aug 20235:51 pmRNSPDS Biotech: Submission of Phase 3 Protocol to FDA
3rd Jul 20237:00 amRNSGrant of Options, Issue of Shares, Director/PDMR
30th Jun 20237:00 amRNSDName-iT Holdings Limited Fundraising
29th Jun 202311:04 amRNSResult of AGM & Board Changes
22nd Jun 20237:00 amRNSVortex Fundraising
14th Jun 20233:31 pmRNSPDS Announces Achievement of Efficacy Threshold
7th Jun 20237:00 amRNSDirector/PDMR Shareholding
6th Jun 20237:00 amRNSNotice of AGM
31st May 20237:01 amRNSPreliminary Results for the year ended 31 Dec 2022
31st May 20237:00 amRNSBoard Changes
26th May 20239:39 amRNSPDS Biotech Announces Interim Data
24th May 20237:00 amRNSSofant and Inmarsat announce joint development
15th May 20233:16 pmRNSPDS Business Update and First Quarter Results
2nd May 20237:00 amRNSGlycotest, Inc. Fundraising
3rd Apr 20237:00 amRNSBusiness Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.